# S-Quatre Corporation

> S-Quatre Corporation is a VC fund in Tokyo backing Health Care and Medical. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 2
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kidswell-bio-corporation/
- Website: https://www.kidswellbio.com/

S-Quatre Corporation is a VC fund in Tokyo focused on Health Care and Medical. S-Quatre is a biomedicine company that provides healthcare solutions as well as the creation of new medications and therapeutics.

## Contacts

5 contacts available for S-Quatre Corporation. Shizune tracks 2 team members at S-Quatre Corporation. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kidswell-bio?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Medical | 1 | 50% |
| Biotechnology | 1 | 50% |
| Manufacturing | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 1 | 50% |
| Corporate Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 1 | 50% |
| United Kingdom | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Masaharu Tani | President & CEO | 0 | https://shizune.co/investors/profile/masaharu-tani-35ef |
| Masayuki Kawakami | Corporate Officer, CTO | 0 | https://shizune.co/investors/profile/masayuki-kawakami-3a6f |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alfenax Biologics | Alfenax Biologics is a Japanese joint venture established by Mycenax Biotech, Alfresa Holdings, Kidswell Bio Corporation, and Chiome Bioscience to build a dedicated biologics manufacturing base in Japan. |  | Corporate Round | Mar 09, 2026 |  |
| LYMPHOGENiX | LYMPHOGENiX aspires to be a global leader in lymphatic science, addressing unmet needs in both human and animal health. Our purpose is to unleash the lymphatic system's latent potential to tackle real-world health concerns. | $339.6K | Pre-Seed | Jul 08, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Alfresa Holdings](https://shizune.co/investors/profile/alfresa-holdings) — VC Fund, 1 deal together
- AndJ Holdings — VC Fund, 1 deal together
- Chiome Bioscience — VC Fund, 1 deal together
- [Glocalink](https://shizune.co/investors/profile/glocalink) — VC Fund, 1 deal together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 1 deal together
- Mycenax Biotech — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does S-Quatre Corporation invest in?

S-Quatre Corporation invests primarily in Health Care, Medical and Biotechnology startups, most often at Pre-Seed and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact S-Quatre Corporation?

Public channels for S-Quatre Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at S-Quatre Corporation?

The team at S-Quatre Corporation includes Masaharu Tani (President & CEO) and Masayuki Kawakami (Corporate Officer, CTO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co